76.6%
radiology's share of the AI-enabled medical devices authorised by the FDA to the end of 2025; cardiovascular 9.6%, neurology 4.5%
What the chart shows
Radiology dominates the FDA’s list of AI-enabled medical devices: 1,039 of the 1,357 authorised to the end of 2025, or 76.6%. Cardiovascular devices come next with 130 (9.6%), then neurology with 61 (4.5%).
The other 14 specialties share 127 devices. Anaesthesiology (23), gastroenterology-urology (21) and haematology (20) are the only others with 20 or more. Eleven specialties have ten or fewer, and immunology has one.
Key numbers
| Measure | Value |
|---|---|
| Radiology | 1,039 |
| Cardiovascular | 130 |
| Neurology | 61 |
| Anaesthesiology | 23 |
| Gastroenterology-urology | 21 |
| All specialties | 1,357 |
How to read it
- Specialty as assigned in the FDA’s device list. Cumulative counts, 1995–2025.
- Authorised covers every route on the FDA’s list, mostly 510(k) clearance; the AI Index’s chart title says ‘approved’.
- The data file spells clinical toxicology ‘Toxcicology’; corrected here, with British spelling for specialty names.
Source: FDA, 2025, via the AI Index Report 2026 (Stanford HAI), figure 6.2.7: Number of AI medical devices approved by the FDA by specialty, 1995–2025 (sum). Chart and text by AI Adoption.
Numbers checked against the published data on 20 October 2026.
Download the data (CSV) · Cite this chart
Numbers checked against the published data on 20 October 2026.
Download the data (CSV) · Cite this chart
Discussion